Skip to main content

Table 2 Primary and secondary endpoints in patients with or without anticoagulation in unmatched and matched cohorts

From: Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?

 

Unmatched

PSM

non-AC n = 138

AC n = 288

p1

non-AC n = 111

AC n = 111

p2

Primary endpoint

PDVT/ PE, n (%)

7 (5.1)

14 (4.9)

0.925

6 (5.4)

3 (2.7)

0.499

PDVT, n (%)

7 (5.1)

12 (4.2)

0.672

6 (5.4)

3 (2.7)

0.499

PE, n (%)

1 (0.7)

4 (1.4)

1.000

1 (0.9)

0 (0.0)

1.000

All-cause mortality, n (%)

41 (29.7)

47 (16.3)

0.001

31 (27.9)

21 (18.9)

0.113

Thrombosis related death, n (%)

0 (0.0)

0 (0.0)

-

0 (0.0)

0 (0.0)

-

Cardiovascular death, n (%)

4 (2.9)

8 (2.8)

1.000

2 (1.8)

3 (2.7)

0.651

Secondary endpoint

Thrombosis resolution, n (%)

58 (42.0)

155 (53.8)

0.023

48 (43.2)

57 (51.4)

0.226

Bleeding, n (%)

9 (6.5)

8 (2.8)

0.065

6 (5.4)

5 (4.5)

0.757

  1. AC Anticoagulation, PDVT Proximal deep venous thrombosis, PE Pulmonary embolism, PSM Propensity score matching